Compare HUIZ & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUIZ | CLGN |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 18.4M |
| IPO Year | 2019 | 2015 |
| Metric | HUIZ | CLGN |
|---|---|---|
| Price | $1.70 | $0.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.30 | ★ $11.00 |
| AVG Volume (30 Days) | 5.3K | ★ 36.5K |
| Earning Date | 03-27-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.67 | $1,596.12 |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $0.50 |
| 52 Week High | $4.16 | $4.98 |
| Indicator | HUIZ | CLGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 45.41 |
| Support Level | $1.60 | $0.50 |
| Resistance Level | $2.19 | $0.73 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 28.39 | 30.74 |
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.